Department of Medicine, Mayo Clinic, Rochester, MN.
Department of Health Sciences Research, Mayo Clinic, Rochester, MN; William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN.
Mayo Clin Proc. 2016 Feb;91(2):149-56. doi: 10.1016/j.mayocp.2015.12.002.
To determine whether participation in early cardiac rehabilitation (CR) after heart transplant (HTx) affects long-term survival.
A retrospective review was conducted in 201 patients who underwent HTx at Mayo Clinic between June 1, 2000, and July 31, 2013. Patients were excluded with multiorgan transplant, no CR data, and follow-up less than 90 days after HTx. Demographic and exercise data at baseline before HTx were collected. Post-HTx exercise capacity, biopsy, CR data, and medications were collected at 1 through 5 and 10 years.
Overall survival at 1, 5, and 10 years was 98%, 88%, and 82%, respectively; 29 patients died. Number of CR sessions attended in the first 90 days after HTx predicted survival in multivariate regression, controlling for baseline post-HTx 6-minute walk test (6MWT) results and rejection episodes (hazard ratio, 0.90; 95% CI, 0.82-0.97; P=.007). Additional univariate predictors of survival included pre-HTx 6MWT results, weight at HTx, and body mass index and systolic blood pressure at CR enrollment. Pre-HTx 6MWT results, body mass index, and post-HTx were associated with improvement in peak oxygen consumption.
This report demonstrates, for the first time, an association between CR and long-term survival in patients after HTx. Further work should clarify the most beneficial aspects of CR.
确定心脏移植(HTx)后早期心脏康复(CR)的参与是否会影响长期生存。
对 2000 年 6 月 1 日至 2013 年 7 月 31 日期间在梅奥诊所接受 HTx 的 201 例患者进行了回顾性研究。排除多器官移植、无 CR 数据和 HTx 后随访时间少于 90 天的患者。收集 HTx 前基线的人口统计学和运动数据。收集 HTx 后 1 年至 5 年和 10 年的运动能力、活检、CR 数据和药物数据。
1、5 和 10 年的总生存率分别为 98%、88%和 82%;29 例患者死亡。多变量回归分析显示,HTx 后 90 天内参加的 CR 次数预测生存,控制了基线后 6 分钟步行试验(6MWT)结果和排斥发作(风险比,0.90;95%置信区间,0.82-0.97;P=.007)。生存的其他单变量预测因素包括 HTx 前的 6MWT 结果、HTx 时的体重、CR 登记时的体重指数和收缩压。HTx 前的 6MWT 结果、体重指数和 HTx 后与峰值耗氧量的改善相关。
本报告首次证明了 HTx 后患者的 CR 与长期生存之间存在关联。进一步的研究应该阐明 CR 最有益的方面。